Hyperplexed Quantum Dots for Multidimensional Cell Classification in Intact Tissue
Project Number3R01EB032249-03S1
Former Number5R01EB032249-03
Contact PI/Project LeaderSMITH, ANDREW MICHAEL
Awardee OrganizationUNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
Description
Abstract Text
ABSTRACT
The goal of this Bioengineering Research Grant (BRG) proposal is to develop fluorescent labels for single-cell
classification through imaging of intact three-dimensional tissue. We are focusing on semiconductor quantum
dots (QDs), nanocrystals that exhibit bright fluorescence and unique optical and electronic properties. We
designed new classes of QDs which we propose will allow quantitative, multispectral analysis of 30 or more
distinct molecules so that hyperspectral light sheet microscopy can be used to proteomically profile and
comprehensively map 20 or more distinct cell types throughout an intact tissue after a single staining step. This
technology addresses an outstanding bottleneck in optical microscopy of three-dimensional tissue, for which
only 3 distinct molecular markers can be easily distinguished, limiting the capacity to precisely classify cell types
and to co-localize different cell types. This proposal comes at a time when new light sheet microscopes have
recently become widely available for full-thickness imaging of optically cleared tissues at sub-cellular resolution
such that rapid advances in multiplexing could yield rapid impacts. As an example, the investigators of this project
developed workflows to optically clear, immunolabel, and image intact adipose tissues from lean and obese
rodent models, in addition to software to comprehensively identify cells based on fluorescent immunostains, and
deep learning algorithms to automate microenvironment segmentation. With these advances, we were able to
discover new classes of immune microenvironments in adipose tissue that are believed to promote comorbidities
of obesity, such as type 2 diabetes and heart disease. However key hypotheses regarding the nature of these
microenvironments cannot be readily addressed until we can discretely categorize cells based on their molecular
expression patterns within their contextual microenvironments. In this proposal, our technological goal is to
develop fluorophores for high-content multiplexing in intact tissues. Our biological goal is to use these tools to
understand immune cell microenvironments that regulate adipose tissue in the state of obesity. Our Specific
Aims are to (1) engineer the photophysics of new classes of QD-based labels, (2) conjugate these labels to
antibody fragments and validate their target specificity as molecular probes, (3) quantitatively evaluate cell
labeling and classification accuracy in three-dimensional adipose tissue, and (4) apply probe panels to quantify
adipose immune microenvironments at the cellular level in the lean and obese states. This is a collaborative
proposal between engineers and scientists with expertise in quantum dots and molecular probes (Andrew Smith),
advanced optical microscopy (Paul Selvin), biomedical image computing (Mark Anastasio), cellular immunology
(Erik Nelson), and animal models of obesity (Kelly Swanson).
Public Health Relevance Statement
NARRATIVE
Classification of cells within human tissues is essential for understanding states of health and disease. In this
proposal, we will develop a new class of fluorescent label that increases the number of molecular classification
markers for cells by an order of magnitude. These labels function within intact, three-dimensional tissue, an
attribute that we will use to map the local environments of adipose tissue immune cells that are thought to
determine comorbid outcomes of obesity.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
041544081
UEI
Y8CWNJRCNN91
Project Start Date
01-January-2024
Project End Date
31-March-2025
Budget Start Date
01-January-2024
Budget End Date
31-March-2024
Project Funding Information for 2024
Total Funding
$21,381
Direct Costs
$15,121
Indirect Costs
$6,260
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$21,381
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R01EB032249-03S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01EB032249-03S1
Patents
No Patents information available for 3R01EB032249-03S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01EB032249-03S1
Clinical Studies
No Clinical Studies information available for 3R01EB032249-03S1
News and More
Related News Releases
No news release information available for 3R01EB032249-03S1
History
No Historical information available for 3R01EB032249-03S1
Similar Projects
No Similar Projects information available for 3R01EB032249-03S1